Where aldehydes are used for disinfection we consider 30 minutes contact time
for difficult viruses like African Swine Fever (ASF) virus to be adequate.  
Coronaviruses
like PEDv TGE IBV and the SARS virus are much easier to inactivate than ASF 
virus.
I'd consider the SARS virus to be similar to Infectious Bronchitis Virus which 
is systemic
and affects a wide variety of tissues.

Inactivating a virus in a chunk of tissue is more challenging than disinfection 
of contaminated
fomites but I see no reason to think that routine fixation times would not 
completely inactivate
the SARS coronavirus.  The concentrations of aldehyde for fixation are at least 
10 times higher
than the highest concentrations used when aldehydes are employed for 
disinfection.

I'd be more concerned about the container than the contents.

For necropsy samples from your human specimens there is not generally any rush 
to get the results
so the CDC's C.Y.A. time doesn't cause trouble but waiting 72 hours for a 
surgical path result
would seem to be just wasting time.

E. Wayne Johnson DVM
Enable AgTech
Beijing


Tony Henwood (SCHN) via Histonet wrote:
Hi Richard,

It will depend on the size of the tissue and the source.
Lung tissue is the major concern. Other tissues not affected as much (based on 
the burgeoning literature on Covid-19).
Routine fixation time are applicable, remembering that the alcohols and heated 
wax will also inactivate the virus (triple whammy).
I suppose that I better add a reference:

https://www.tandfonline.com/doi/full/10.1080/01478885.2020.1734718


-----Original Message-----
From: Cartun, Richard via Histonet [mailto:histonet@lists.utsouthwestern.edu]
Sent: Tuesday, 21 April 2020 6:51 AM
To: histonet@lists.utsouthwestern.edu
Subject: [Histonet] Formalin fixation for COVID-19 positive tissues .....

How long are you fixing surgical tissue specimens from COVID-19 positive patient's before 
tissue processing?  I know that the CDC is recommending "72" hours for autopsy 
tissues, but, to me, that seems excessive for surgical pathology specimens.  Any 
information that you can share on this subject would be appreciated.  Thank you and stay 
safe.

Richard

Richard W. Cartun, MS, PhD
Director, Histology & The Martin M. Berman, MD Immunopathology/Morphologic 
Proteomics Laboratory Director, Biospecimen Collection Programs Assistant Director, 
Anatomic Pathology Hartford Hospital
80 Seymour Street
Hartford, CT  06102
(860) 972-1596 (Office)
(860) 545-2204 (Fax)
richard.car...@hhchealth.org<mailto:richard.car...@hhchealth.org>


This e-mail message, including any attachments, is for the sole use of the 
intended recipient(s) and may contain confidential and privileged information. 
Any unauthorized review, use, disclosure, or distribution is prohibited. If you 
are not the intended recipient, or an employee or agent responsible for 
delivering the message to the intended recipient, please contact the sender by 
reply e-mail and destroy all copies of the original message, including any 
attachments.
_______________________________________________
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

This message is intended for the addressee named and may contain confidential 
information. If you are not the intended recipient, please delete it and notify 
the sender.

Views expressed in this message are those of the individual sender, and are not 
necessarily the views of NSW Health or any of its entities.


_______________________________________________
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet



_______________________________________________
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

Reply via email to